98%
921
2 minutes
20
Tanshinones, the major bioactive diterpenes in Salvia miltiorrhiza Bunge, are widely used to treat cardiovascular and cerebrovascular diseases. While jasmonates (JAs) are known to modulate tanshinones accumulation, the molecular link between JA signalling and tanshinone biosynthesis remains unclear. Here, we identify SmWRKY33, a JA-responsive WRKY transcription factor, as a key regulator of tanshinone biosynthesis through multiomic and genetic analyses. SmWRKY33 is highly expressed in the roots of S. miltiorrhiza. SmWRKY33 directly binds to the promoters of SmCPS1, SmKSL1, SmCYP76AH3, SmCYP71D373 and Sm2-ODD14, activating their transcription and promoting tanshinones accumulation. Notably, SmWRKY33 interacts with SmJAZ8, a JA signalling repressor, which suppresses its transcriptional activity on tanshinone biosynthetic genes. Additionally, SmMPK3 is responsive to JA signaling and functions as a positive regulator of tanshinone biosynthesis in S. miltiorrhiza. Furthermore, SmMPK3 directly associates with and phosphorylates SmWRKY33, a modification that enhances its transcriptional activity and DNA-binding capacity. Collectively, our findings elucidate how JA signalling integrates with MAPK phosphorylation to regulate specialised metabolism and provide molecular targets for metabolic engineering to enhance tanshinones production in S. miltiorrhiza.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/pbi.70340 | DOI Listing |
Plant Biotechnol J
September 2025
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Tanshinones, the major bioactive diterpenes in Salvia miltiorrhiza Bunge, are widely used to treat cardiovascular and cerebrovascular diseases. While jasmonates (JAs) are known to modulate tanshinones accumulation, the molecular link between JA signalling and tanshinone biosynthesis remains unclear. Here, we identify SmWRKY33, a JA-responsive WRKY transcription factor, as a key regulator of tanshinone biosynthesis through multiomic and genetic analyses.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong Province, China.
This study aims to identify the primary active components of Danshen (Salvia miltiorrhiza) and explore the potential mechanisms underlying its therapeutic effect on Kawasaki disease (KD). Active components of Danshen and their action targets were screened using traditional Chinese medicine systems pharmacology and SwissTargetPrediction databases. KD-related targets were retrieved from Online Mendelian Inheritance in Man, Pharmacogenomics Knowledge Base, and GeneCards databases.
View Article and Find Full Text PDFPlant Biotechnol J
September 2025
Zhejiang Provincial International S&T Cooperation Base for Active Ingredients of Medicinal and Edible Plants and Health, Zhejiang Provincial Key TCM Laboratory for Chinese Resource Innovation and Transformation, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Zhejiang, Hangzh
Salvia miltiorrhiza produces pharmacologically bioactive diterpenoid tanshinones which are regulated by jasmonate (JA) and abscisic acid (ABA) signalling, while their crosstalk in this process remains unclear. Here, we demonstrated that MeJA and ABA acted synergistically to enhance tanshinone biosynthesis. We reported that a novel bZIP transcription factor, SmbZIP5, was involved in ABA- and JA-induced tanshinone biosynthesis.
View Article and Find Full Text PDFBiol Pharm Bull
August 2025
Department of Molecular and Cellular Pharmacology, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Cell transplantation therapy is a promising new treatment for myocardial infarction and heart failure. Developing methods to promote the engraftment of cardiac stem cells into cardiac tissue and their differentiation into cardiac cells is a strategy for improving the efficacy of cell transplantation therapy. Tanshinone VI (TanVI), a component extracted from the roots of Salvia miltiorrhiza Bunge (Labiatae), is a possible pharmacological agent for ischemic heart disease.
View Article and Find Full Text PDFTheranostics
August 2025
School of Pharmaceutical Sciences, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
The limitations of current depression treatments highlight the importance of developing new therapeutic strategies. Tanshinone I (Tan I), a naturally occurring lipophilic diterpene compound, has promising activities including inflammation inhibition, cellular autophagy or apoptosis modulation, and anti-oxidative stress. However, the potential antidepressant effects of Tan I and the mechanism behind its action have yet to be established.
View Article and Find Full Text PDF